Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicabl... (32018D0945)
INHALT
Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance.)
- COMMISSION IMPLEMENTING DECISION (EU) 2018/945
- of 22 June 2018
- on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions
- (Text with EEA relevance)
- Article 1
- Article 2
- Article 3
- Article 4
- ANNEX I
- Communicable diseases and related special health issues to be covered by the epidemiological surveillance network
- 1. DISEASES
- 2. SPECIAL HEALTH ISSUES
- ANNEX II
- 1.
- EXPLANATION OF THE SECTIONS USED IN THE DEFINITION AND CLASSIFICATION OF CASES
- CLINICAL CRITERIA
- LABORATORY CRITERIA
- EPIDEMIOLOGICAL CRITERIA AND EPIDEMIOLOGICAL LINK
- CASE CLASSIFICATION
- POSSIBLE CASE
- PROBABLE CASE
- CONFIRMED CASE
- LABORATORY-CONFIRMED CASE WITH CLINICAL CRITERIA
- LABORATORY-CONFIRMED CASE WITH UNKNOWN CLINICAL CRITERIA
- LABORATORY-CONFIRMED CASE WITHOUT CLINICAL CRITERIA
- 2.
- ABBREVIATION LIST
- 3.
- CASE DEFINITIONS OF COMMUNICABLE DISEASES
- 3.1. ANTHRAX
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.2. BOTULISM
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.3. BRUCELLOSIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.4.
- CAMPYLOBACTER
- ENTERITIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- Antimicrobial resistance
- 3.5. CHIKUNGUNYA VIRUS DISEASE
- Clinical Criteria
- (2)
- Laboratory Criteria
- (3)
- A. Probable case
- B. Confirmed case
- Epidemiological Criteria
- Case Classification
- 3.6. CHLAMYDIAL INFECTION, INCLUDING CHLAMYDIAL LYMPHOGRANULOMA (VENEREUM) (LGV)
- Clinical Criteria
- Laboratory Criteria
- Chlamydial infection non-LGV
- LGV
- Epidemiological Criteria
- Case Classification
- 3.7. CHOLERA
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.8. CREUTZFELDT-JAKOB DISEASE (CJD)
- Preconditions
- Clinical Criteria
- Diagnostic Criteria
- Diagnostic criteria for case confirmation:
- Diagnostic criteria for a probable or a possible case:
- Epidemiological Criteria
- Case Classification
- 3.9. CRYPTOSPORIDIOSIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.10. DENGUE
- Clinical Criteria
- (9)
- Laboratory Criteria
- (10)
- A. Probable case
- B. Confirmed case
- Epidemiological Criteria
- Case Classification
- 3.11. DIPHTHERIA
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.12. ECHINOCOCCOSIS
- Clinical Criteria
- Diagnostic Criteria
- Case Classification
- 3.13. GIARDIASIS (LAMBLIASIS)
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.14. GONOCOCCAL INFECTION
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- Antimicrobial resistance
- 3.15.
- HAEMOPHILUS INFLUENZAE
- INFECTION, INVASIVE DISEASE
- Clinical Criteria
- Laboratory Criteria
- Case Classification
- 3.16. ACUTE HEPATITIS A
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.17. HEPATITIS B (12)
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.18. HEPATITIS C (13)
- Clinical Criteria
- Laboratory Criteria
- Case Classification
- 3.19. HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
- Clinical Criteria (AIDS)
- Laboratory Criteria (HIV)
- Case Classification
- 3.20. INFLUENZA
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.21. INFLUENZA A/H5N1
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.22. LEGIONNAIRES' DISEASE
- Clinical Criteria
- Laboratory Criteria
- Laboratory criteria for case confirmation
- Laboratory criteria for a probable case
- Case Classification
- 3.23. LEPTOSPIROSIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.24. LISTERIOSIS
- Clinical Criteria
- Listeriosis in pregnancy:
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.25. LYME NEUROBORRELIOSIS
- Clinical Criteria
- Laboratory Criteria
- A. Confirmed case
- B. Probable case
- Epidemiological Criteria
- Case Classification
- 3.26. MALARIA
- Clinical Criteria
- Laboratory Criteria
- Case Classification
- 3.27. MEASLES
- Clinical Criteria
- Laboratory Criteria
- Epidemiological criteria
- Case Classification
- 3.28.
- MENINGOCOCCAL
- INFECTION, INVASIVE DISEASE
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.29. MUMPS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.30. PERTUSSIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.31. PLAGUE
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.32.
- STREPTOCOCCUS PNEUMONIAE
- INFECTION, INVASIVE DISEASE
- Clinical Criteria
- Laboratory Criteria
- Case Classification
- Antimicrobial resistance:
- 3.33. ACUTE POLIOMYELITIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.34. Q FEVER
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.35. RABIES
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.36. RUBELLA
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.37. CONGENITAL RUBELLA SYNDROME
- Clinical Criteria
- Congenital rubella infection (CRI)
- Congenital rubella syndrome (CRS)
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification Congenital Rubella
- 3.38.
- SALMONELLA
- ENTERITIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- Antimicrobial resistance
- 3.39. SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
- Clinical Criteria
- Laboratory Criteria
- Laboratory criteria for case confirmation
- Laboratory criteria for a probable case
- Epidemiological Criteria
- Case Classification for the inter-epidemic period
- Case Classification during an outbreak
- 3.40. SHIGA TOXIN/VEROCYTOTOXIN-PRODUCING
- E. COLI
- INFECTION (STEC/VTEC), INCLUDING HAEMOLYTIC-URAEMIC SYNDROME (HUS)
- Clinical Criteria
- STEC/VTEC diarrhoea
- HUS
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.41. SHIGELLOSIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- Antimicrobial resistance
- 3.42. SMALLPOX
- Clinical Criteria
- Laboratory Criteria
- Laboratory criteria for case confirmation
- Laboratory criteria for a probable case
- Epidemiological Criteria
- Case Classification
- 3.43. SYPHILIS
- Clinical Criteria
- Primary syphilis
- Secondary syphilis
- Early latent syphilis (< 1 year)
- Laboratory Criteria
- Epidemiological Criteria
- Primary/secondary syphilis
- Early latent syphilis
- Case Classification
- 3.44. CONGENITAL SYPHILIS
- Clinical Criteria
- Laboratory Criteria
- Laboratory criteria for case confirmation
- Laboratory criteria for a probable case
- Epidemiological Criteria
- Case Classification
- 3.45. TETANUS
- Clinical Criteria
- Case Classification
- 3.46. TICK-BORNE VIRAL ENCEPHALITIS
- Clinical Criteria
- Laboratory Criteria
- (19)
- Laboratory criteria for case confirmation:
- Laboratory criteria for a probable case:
- Epidemiological Criteria
- Case Classification
- 3.47. CONGENITAL TOXOPLASMOSIS
- Clinical Criteria
- Laboratory Criteria
- Case Classification
- 3.48. TRICHINELLOSIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.49. TUBERCULOSIS
- Clinical Criteria
- Laboratory Criteria
- Laboratory criteria for case confirmation
- Laboratory criteria for a probable case
- Case Classification
- Antimicrobial resistance
- 3.50. TULARAEMIA
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.51. TYPHOID AND PARATYPHOID FEVERS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.52. VIRAL HAEMORRHAGIC FEVERS (VHF)
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.53. WEST NILE VIRUS INFECTION (WNV)
- Clinical Criteria
- Laboratory Criteria
- Laboratory test for case confirmation
- Laboratory test for a probable case
- Epidemiological Criteria
- Case Classification
- 3.54. YELLOW FEVER
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.55. ENTERITIS DUE TO YERSINIA ENTEROCOLITICA OR
- YERSINIA PSEUDOTUBERCULOSIS
- Clinical Criteria
- Laboratory Criteria
- Epidemiological Criteria
- Case Classification
- 3.56. ZIKA VIRUS DISEASE
- Clinical Criteria
- Laboratory Criteria
- A. Confirmed case
- B. Probable case
- Epidemiological Criteria
- Case Classification
- 3.57. CONGENITAL ZIKA VIRUS DISEASE
- Clinical Criteria
- Laboratory Criteria
- A. Confirmed case
- Epidemiological Criteria
- Case Classification
- 4.
- CASE DEFINITIONS OF SPECIAL HEALTH ISSUES
- 4.1. GENERAL CASE DEFINITION OF NOSOCOMIAL INFECTION (OR ‘HEALTHCARE-ASSOCIATED INFECTION (HAI)’)
- 4.1.1.
- BJ: Bone and joint infection
- BJ-BONE: Osteomyelitis
- BJ-JNT: Joint or bursa
- BJ-DISC: Disc space infection
- 4.1.2.
- BSI: Bloodstream infection
- BSI: Laboratory-confirmed bloodstream infection
- 4.1.3.
- CNS: Central nervous system infection
- CNS-IC: Intracranial infection (brain abscess, subdural or epidural infection, encephalitis)
- CNS-MEN: Meningitis or ventriculitis
- CNS-SA: Spinal abscess without meningitis
- 4.1.4.
- CRI: Catheter-related infection
- (21)
- CRI1-CVC: Local CVC-related infection (no positive blood culture)
- CRI1-PVC: Local PVC-related infection (no positive blood culture)
- CRI2-CVC: General CVC-related infection (no positive blood culture)
- CRI2-PVC: General PVC-related infection (no positive blood culture)
- CRI3-CVC: microbiologically confirmed CVC-related bloodstream infection
- CRI3-PVC: microbiologically confirmed PVC-related bloodstream infection
- 4.1.5.
- CVS: Cardiovascular system infection
- CVS-VASC: Arterial or venous infection
- CVS-ENDO: Endocarditis
- CVS-CARD: Myocarditis or pericarditis
- CVS-MED: Mediastinitis
- 4.1.6.
- EENT: Eye, ear, nose, throat, or mouth infection
- EENT-CONJ: Conjunctivitis
- EENT-EYE: Eye, other than conjunctivitis
- EENT-EAR: Ear mastoid
- EENT-ORAL: Oral cavity (mouth, tongue, or gums)
- EENT-SINU: Sinusitis
- EENT-UR: Upper respiratory tract, pharyngitis, laryngitis, epiglottitis
- 4.1.7.
- GI: Gastrointestinal system infection
- GI-CDI:
- Clostridium difficile
- infection
- GI-GE: Gastroenteritis (excl. CDI)
- GI-GIT: Gastrointestinal tract (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis
- GI-HEP: Hepatitis
- GI-IAB: Intraabdominal, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere
- 4.1.8.
- LRI: Lower respiratory tract infection, other than pneumonia
- LRI-BRON: Bronchitis, tracheobronchitis, bronchiolitis, tracheitis, without evidence of pneumonia
- LRI-LUNG: Other infections of the lower respiratory tract
- 4.1.9.
- NEO: Specific neonatal case definitions
- NEO-CSEP: Clinical Sepsis
- NEO-LCBI: Laboratory-confirmed BSI
- NEO-CNSB: Laboratory-confirmed BSI with coagulase-negative staphylococci
- NEO-PNEU: Pneumonia
- NEO-NEC: Necrotising enterocolitis
- 4.1.10.
- PN: Pneumonia
- Positive quantitative culture from minimally contaminated LRT (22) specimen (PN 1)
- Positive quantitative culture from possibly contaminated LRT specimen (PN 2)
- Intubation-associated pneumonia (IAP)
- 4.1.11.
- REPR: Reproductive tract infection
- REPR-EMET: Endometritis
- REPR-EPIS: Episiotomy
- REPR-VCUF: Vaginal cuff
- REPR-OREP: Other infections of the male or female reproductive tract (epididymis, testes, prostate, vagina, ovaries, uterus, or other deep pelvic tissues, excluding endometritis or vaginal cuff infections)
- 4.1.12.
- SSI: Surgical site infection
- Superficial incisional (SSI-S)
- Deep incisional (SSI-D)
- Organ/Space (SSI-O)
- 4.1.13.
- SST: Skin and soft tissue infection
- SST-SKIN: Skin infection
- SST-ST: Soft tissue (necrotizing fascitis, infectious gangrene, necrotizing cellulitis, infectious myositis, lymphadenitis, or lymphangitis)
- SST-DECU: Decubitus ulcer, including both superficial and deep infections
- SST-BURN: Burn
- SST-BRST: Breast abscess or mastitis
- 4.1.14.
- SYS: Systemic infection
- SYS-DI: Disseminated infection
- SYS-CSEP: treated unidentified severe infection
- 4.1.15.
- UTI: Urinary tract infection
- UTI-A: microbiologically confirmed symptomatic UTI
- UTI-B: not microbiologically confirmed symptomatic UTI
- 4.2. GENERAL CASE DEFINITION OF BLOOD STREAM INFECTION DUE TO SPECIFIC PATHOGENS
- Clinical criteria
- Laboratory criteria
- Epidemiological criteria
- Case classification
- Antimicrobial resistance
- 4.3. GENERIC CASE DEFINITION AND CLASSIFICATION OF ANTIMICROBIAL REISTANCE TO ANTIMICROBIAL AGENTS
- Clinical resistance to antimicrobial agents
- Definition
- Classification
- Clinically Susceptible (S)
- Clinically Intermediate (I)
- Clinically Resistant (R)
- Pandrug-resistant (PDR)
- Microbiological resistance to antimicrobial agents
- Phenotypic definition
- Phenotypic classification
- Wild-type (WT) phenotype
- Non-wild-type (NWT) phenotype
- Identification of an acquired antimicrobial resistance mechanism
- (for example, drug inactivating enzyme, modification of drug target protein type, efflux pump)
- Genotypic definition
- Genotypic classification
Feedback